Efficacy of the NVX-CoV2373 COVID-19 Vaccine in Patients With vs Without HIV
Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.
Researchers assessed humoral responses to COVID-19 vaccination with NVX-CoV2373 among patients with vs without HIV infection on the basis of prior COVID-19 exposure.
Researchers assessed whether adeno-associated virus vectored immunoprophylaxis with AAV8-VRC07 produces broadly neutralizing antibodies in patients with HIV.
Among persons living with HIV who have anal HSILs, those who receive treatment have a lower rate of progression to anal cancer.
Researchers assessed the incidence of pneumocystis pneumonia among individuals in Germany between 2014 and 2019.
Investigators assessed the risk for incident diabetes and hyperglycemia among patients with HIV infection receiving integrase strand transfer inhibitors.
Researchers assessed the prevalence of sexually transmitted infections during pregnancy and factors associated with preterm birth among women with HIV infection.
People with HIV (PWH) have an increased risk for breakthrough severe acute respiratory syndrome coronavirus 2 infection after vaccination.
A team of researchers analyzed the virologic response of hepatitis C virus to direct-acting antivirals in patients with HIV.
Researchers estimated uptake of the meningococcal A, C, W, Y vaccine among individuals with newly diagnosed HIV infection at increased risk for meningococcal disease.
Researchers assessed the effects of long-term antiretroviral therapy among women of reproductive age with HIV infection and HIV-exposed children.